Acellular pertussis vaccines.
作者信息
Miller E
机构信息
Immunisation Division, Communicable Disease Surveillance Centre, London.
出版信息
Arch Dis Child. 1995 Nov;73(5):390-1. doi: 10.1136/adc.73.5.390.
Abstract
摘要
相似文献
1
Acellular pertussis vaccines.无细胞百日咳疫苗
Arch Dis Child. 1995 Nov;73(5):390-1. doi: 10.1136/adc.73.5.390.
2
A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.白喉、破伤风、五组分无细胞百日咳、脊髓灰质炎病毒和b型流感嗜血杆菌联合疫苗
Expert Rev Vaccines. 2005 Dec;4(6):793-805. doi: 10.1586/14760584.4.6.793.
3
The effectiveness of whole-cell pertussis vaccines.
Dev Biol Stand. 1997;89:171-4.
4
ACIP issues statement on acellular pertussis vaccine.
Am Fam Physician. 1992 Jul;46(1):286, 291.
5
6
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国，一项比较联合使用无细胞百白破、灭活脊髓灰质炎（DTaP-IPV）疫苗与分别单独使用百白破（DTaP）和脊髓灰质炎（IPV）疫苗的免疫原性和安全性的随机对照研究：在婴儿中进行的研究。
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
7
Why do pertussis vaccines fail?百日咳疫苗为何会失效？
Pediatrics. 2012 May;129(5):968-70. doi: 10.1542/peds.2011-2594. Epub 2012 Apr 23.
8
Acellular pertussis vaccines: the next step.
Dev Biol Stand. 1997;89:363-5.
9
Japanese clinical trials with Takeda acellular pertussis vaccine.武田无细胞百日咳疫苗的日本临床试验。
Tokai J Exp Clin Med. 1988;13 Suppl:15-9.
10
Acellular vaccines for preventing whooping cough in children.用于预防儿童百日咳的无细胞疫苗。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD001478. doi: 10.1002/14651858.CD001478.pub4.
引用本文的文献
1
Which strategy for pertussis vaccination today?如今百日咳疫苗接种采用哪种策略？
Paediatr Drugs. 2002;4(5):299-313. doi: 10.2165/00128072-200204050-00003.
本文引用的文献
1
Acellular pertussis vaccines--a solution to the pertussis problem?无细胞百日咳疫苗——解决百日咳问题的办法？
J Infect Dis. 1993 Jul;168(1):15-20. doi: 10.1093/infdis/168.1.15.
2
Pertussis vaccination.
Lancet. 1994 Dec 3;344(8936):1575-6. doi: 10.1016/s0140-6736(94)90385-9.
3
The concept of pertussis as a toxin-mediated disease.百日咳作为一种毒素介导疾病的概念。
Pediatr Infect Dis. 1984 Sep-Oct;3(5):467-86. doi: 10.1097/00006454-198409000-00019.
4
Serospecific protection of mice against intranasal infection with Bordetella pertussis.小鼠针对百日咳博德特氏菌鼻内感染的血清特异性保护作用。
Vaccine. 1989 Aug;7(4):321-4. doi: 10.1016/0264-410x(89)90193-x.
5
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial.
Vaccine. 1990 Oct;8(5):457-61. doi: 10.1016/0264-410x(90)90246-i.
6
Developments in pertussis immunisation in Japan.日本百日咳免疫接种的发展
Lancet. 1990 Jul 7;336(8706):30-2. doi: 10.1016/0140-6736(90)91530-n.
7
Efficacy of whole-cell pertussis vaccine in preschool children in the United States.全细胞百日咳疫苗在美国学龄前儿童中的效力
JAMA. 1992 May 27;267(20):2745-9.
8
Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
FEMS Microbiol Immunol. 1992 Oct;5(4):161-70. doi: 10.1111/j.1574-6968.1992.tb05898.x.
9
The epidemiology of pertussis in England and Wales.英格兰和威尔士的百日咳流行病学
Commun Dis Rep CDR Rev. 1992 Dec 4;2(13):R152-4.
Zotero 插件